Announced
Synopsis
YOOV, an artificial intelligence as a service provider, agreed to merge with Avalon GloboCare, a commercial-stage company developing and delivering precision diagnostics and clinical laboratory services. Financial terms were not disclosed. “We believe this transaction is in the best interest of our shareholders, providing a unique opportunity to unlock value and participate in the future of AI-driven automation. We believe that YOOV’s advanced AI technology, strong market presence, and rapid growth trajectory represent a compelling market opportunity. We believe this merger has the potential to drive innovation, scalability, and long-term shareholder value," Dr. David Jin, M.D., Ph.D., Avalon GloboCare CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite
Bidder Team (1)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy